DOI QR코드

DOI QR Code

Stimultaneous Determination of Ephedrine Alkaloids in Ephedra sinica and Wolbigachul-tang by High Performance Liquid Chromatography

고성능 액체 크로마토그래피를 이용한 마황 및 월비가출탕 전탕액에서 에페드린류의 동시분석

  • Song, Miyoung (The Reset Korean Medicine Clinic) ;
  • Kim, Jung-Ok (National Institute for Korean Medicine Development) ;
  • Leem, HyunHee (National Institute for Korean Medicine Development) ;
  • Kim, Hojun (Department of Rehabilitation Medicine of Korean Medicine, Dongguk University)
  • Received : 2020.11.06
  • Accepted : 2020.12.14
  • Published : 2020.12.30

Abstract

Objectives: Ephedra sinica and Wolbigachul-tang which contains Ephedra sinica are used to treat obesity in Korean medicine. The aim of this study was to analyze the quantities of ephedrine alkaloids by high-performance liquid chromatography. Methods: The analysis was performed using a YMC-Triat C18 column with operating at 25℃, and UV detection at 210 nm. The mobile phase used a gradient flow with 0.1% H3PO4 in water and acetonitrile. Specificity, linearity, precision, accuracy, limit of detection, and limit of quantification were measured for validation anaylsis. This method was applied to analyze the quantities of ephedrine alkaloids in Ephedra sinica and Wolbigachul-tang. Results: The concentration per Ephedra sinica (gram) of ephedrine and pseudoephedrine in Ephedra sinica decoction are 4.74±0.22 mg and 2.19±0.10 mg, respectively and in Wolbigachul-tang decoction are 6.39±0.34 mg and 2.97±0.21 mg, respectively. The retention time of ephedrine was 23.6 min and that of pseudoephedrine was 25.8 min, and norephedrine and methylephedrine were not detected. Conclusions: In conclusion, analyzed the concentration of ephedrine alkaloids in Ephedra sinica and Wolbigachul-tang by the developed validation method.

Keywords

References

  1. Association of Professors of Herbology in Korean Medicine. Herbology. Seoul : Younglimsa. 1998 : 121-3.
  2. Hwang MJ, Shin HD, Song MY. Review of literature on herbal medicines for the treatment of obesity in Korea -Mainly papers since 2000. J Korean Med Rehabil. 2006 ; 16(3) : 65-82.
  3. Andraws R, Chawla P, Brown DL. Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis. 2005 ; 47(4) : 217-25. https://doi.org/10.1016/j.pcad.2004.07.006
  4. Kim HJ, Park JM, Kim JA, Ko BP. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double-blind clinical trial in Korean premenopausal women. J Acupunct Meridian Stud. 2008 ; 1(2) : 128-38. https://doi.org/10.1016/S2005-2901(09)60033-9
  5. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002 ; 26(5) : 593-604. https://doi.org/10.1038/sj.ijo.0802023
  6. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001 ; 25(3) : 316-24. https://doi.org/10.1038/sj.ijo.0801539
  7. Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004 ; 28(11) : 1411-9. https://doi.org/10.1038/sj.ijo.0802784
  8. Greenway FL, de Jonge L, Blanchard D, Frisard M, Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obes Res 2004 ; 12: 1152-7. https://doi.org/10.1038/oby.2004.144
  9. Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, et al. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Int J Obes (Lond). 2006 ; 30(10) : 1545-56. https://doi.org/10.1038/sj.ijo.0803283
  10. Korea Institute of Oriental Medicine. Obesity, Korean medicine clinical practice guideline. Seoul : Elsevier Korea. 2016 : 84-90.
  11. Bukowiecki L, Jahjah L, Follea N. Ephedrine, a potential slimming drug, directly stimulates thermogenesis in brown adipocytes via beta-adrenoreceptors. Int J Obes. 1982 ; 6(4) : 343-50.
  12. Kim H, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang(Ephedra sinica) prescription in obesity. J Korean Med Obes Res. 2007 ; 7(2) : 27-37.
  13. Korea Food and Drug Administration. The Korean pharmacopoeia. 12th ed. Seoul : The Research Foundation for Pharmaceutical Quality. 2019.
  14. Kazuhiko S, Toshiyuki O, Tetsuo M. A simultaneous determination of norephedrine, pseudoephedrine, ephedrine and methylephedrine in Ephedrae Herba and oriental pharmaceutical preparations by ion-pair high-performance liquid chromatography. Chem Pharm Bull. 1983 ; 31(7) : 2359-65. https://doi.org/10.1248/cpb.31.2359
  15. Lee MK, Cheng BW, Che CT, Hsieh DP. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000 ; 56(2) : 424-30. https://doi.org/10.1093/toxsci/56.2.424
  16. Okamura N, Miki H, Harada T, Yamashita S, Masaoka Y, Nakamoto Y, et al. Simultaneous determination of ephedrine, pseudoephedrine, norephedrine and methylephedrine in Kampo medicines by high-performance liquid chromatography. J Pharm Biomed Anal. 1999 ; 20(1-2) : 363-72. https://doi.org/10.1016/S0731-7085(99)00065-5
  17. Package Information of Primatene® Tablets [Internet]. Maryland: Wyeth Consumer Healthcare LLC; 2019 [cit ed Feb 17 2020]. Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9005482c-25ae-d365-33d1-29269532c74d&type=display.
  18. Package Information of SUDAFED® Sinus Congestion [Internet]. Maryland: Johnson & Johnson Consumer Inc; 2019 [cited Feb 17 2020]. Available from: https://www.sudafed.com/products/sudafed-sinus-congestion.